TMO's Quality Score fell 2 points on Tue, Nov 10, to 17. Buying slipped from its highest in 20 days (3 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 6% from Nov 5 to Nov 10.
Up 18% over the five years to Nov 9 while the S&P 500 rose 72%; up 6% since Nov 5.
3 reasons, from its filings, with the timeline, for Pro members.
| Outperforming | Up 56% in 6 months vs the S&P's +2% |
| Latest filing | 8-K, Oct 30 |
Tue Dec 15: Ex-dividend, $0.47 a shareAt the open. Pays Jan 15.
After its last 4 reports it closed -0.5% on average, higher 2 of 4 times.
Excellentfor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
TMO is #1 of 6 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 4 | ||
| Open for its score | ||
| Open for its score |
Expected to report Thu Jan 28, before the open (in 79 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 21, 2026 | -3.3% | +1.0% | +0.8% |
| Jul 23, 2026 | +9.0% | +8.7% | +9.5% |
| Apr 23, 2026 | -8.0% | -9.2% | -9.3% |
Sales grew in six of the last seven years, to $45B in 2025. It made a profit in each of the three years.
RSI 60.3, MACD above signal, above both averages. Not scored.
2 insiders sold $12.7M across 4 filings in the last 6 months. No open-market buys on record. The newest:
16 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: TMO is 1.0% of SCHG, 0.4% of SPYI, and 0.4% of VOO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
“The company encounters aggressive and able competition in virtually all of the markets we serve.”
TMO scores 17 today, which Breakaway calls Excellent. It is #1 of 6 in Measuring & Controlling Devices by Quality Score, with 7 of 14 chart checks firing. Up 6% from Nov 5 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
TMO scores 17 today, which Breakaway calls Excellent (15 to 19). That is #1 of 6 in Measuring & Controlling Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TMO's 17.
2 insiders sold $12.7M across 4 filings in the last 6 months. No open-market buys on record. The newest is Lisa P. Britt, Sr. VP and Chief HR Officer, who sold $2M on Oct 28. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.